Cargando…
Functional inhibition of the RNA‐binding protein HuR sensitizes triple‐negative breast cancer to chemotherapy
Chemotherapy remains the standard treatment for triple‐negative breast cancer (TNBC); however, chemoresistance compromises its efficacy. The RNA‐binding protein Hu antigen R (HuR) could be a potential therapeutic target to enhance the chemotherapy efficacy. HuR is known to mainly stabilize its targe...
Autores principales: | Wei, Lanjing, Zhang, Qi, Zhong, Cuncong, He, Lily, Zhang, Yuxia, Armaly, Ahlam M., Aubé, Jeffrey, Welch, Danny R., Xu, Liang, Wu, Xiaoqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552894/ https://www.ncbi.nlm.nih.gov/pubmed/37357618 http://dx.doi.org/10.1002/1878-0261.13478 |
Ejemplares similares
-
Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis
por: Wu, Xiaoqing, et al.
Publicado: (2020) -
Inhibition of RNA-binding protein HuR reduces glomerulosclerosis in experimental nephritis
por: Liu, Simeng, et al.
Publicado: (2020) -
Targeting RNA-binding protein HuR to inhibit the progression of renal tubular fibrosis
por: Huang, Zhimin, et al.
Publicado: (2023) -
The RNA-Binding Protein HuR in Digestive System Tumors
por: Song, Xiaoqing, et al.
Publicado: (2020) -
The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitro
por: Kaur, Kawaljit, et al.
Publicado: (2017)